{
    "Trade/Device Name(s)": [
        "Selux AST System",
        "Selux Gram-Positive Panel",
        "Model AST Gen 1.0"
    ],
    "Submitter Information": "Selux Diagnostics, Inc.",
    "510(k) Number": "K211759",
    "Predicate Device Reference 510(k) Number(s)": [
        "K131331"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTT",
        "LTW"
    ],
    "Summary Letter Date": "January 18, 2023",
    "Summary Letter Received Date": "June 7, 2021",
    "Submission Date": "June 4, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ampicillin",
        "Clindamycin",
        "Ceftaroline",
        "Daptomycin",
        "Delafloxacin",
        "Eravacycline",
        "Erythromycin",
        "Linezolid",
        "Levofloxacin",
        "Minocycline",
        "Oxacillin",
        "Penicillin",
        "Trimethoprim",
        "Vancomycin",
        "Cefoxitin Screen"
    ],
    "Specimen Type(s)": [
        "Isolated colonies of aerobic microorganisms"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Selux AST System",
        "Sample Prep Station",
        "Inoculator",
        "Analyzer",
        "Computer workstation"
    ],
    "Method(s)/Technology(ies)": [
        "Automated growth-based detection",
        "Broth microdilution",
        "Fluorescence",
        "Optical absorbance",
        "Probe-based metabolic assays"
    ],
    "Methodologies": [
        "Minimum inhibitory concentration (MIC) determination",
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Analyzer",
        "Software",
        "Reagent",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for Selux AST System: automated antimicrobial susceptibility test system for Gram-positive bacteria using broth microdilution and growth-based detection",
    "Indications for Use Summary": "Automated quantitative or qualitative susceptibility testing of most clinically significant aerobic microorganisms using isolated colonies to determine susceptibility of specific Staphylococcus and Enterococcus species to listed antimicrobial agents",
    "fda_folder": "Microbiology"
}